MT-TR and hemophilia A: A similar enTTR-mTTR promoter, but with the mTTR enhancer in the antisense orientation, was used in gene therapies for the treatment of hemophilia A (TAK-754/BAX 888) and hemophilia B (AskBio009/BAX 335) (Figure 3C) [195,197].